ALLENA PHARMACEUTICALS INC's ticker is ALNA and the CUSIP is 018119107. A total of 26 filers reported holding ALLENA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $533,000 | -17.4% | 2,790,964 | 0.0% | 11.54% | +75.3% |
| Q1 2022 | $645,000 | -61.0% | 2,790,964 | 0.0% | 6.58% | -3.7% |
| Q4 2021 | $1,654,000 | -34.3% | 2,790,964 | 0.0% | 6.84% | -38.7% |
| Q3 2021 | $2,518,000 | -30.6% | 2,790,964 | 0.0% | 11.16% | +4.2% |
| Q2 2021 | $3,628,000 | -6.5% | 2,790,964 | 0.0% | 10.71% | +337.0% |
| Q1 2021 | $3,879,000 | +8.6% | 2,790,964 | 0.0% | 2.45% | -1.5% |
| Q4 2020 | $3,572,000 | -13.5% | 2,790,964 | 0.0% | 2.49% | -7.2% |
| Q3 2020 | $4,131,000 | -6.3% | 2,790,964 | 0.0% | 2.68% | -17.7% |
| Q2 2020 | $4,410,000 | +64.1% | 2,790,964 | 0.0% | 3.26% | +12.9% |
| Q1 2020 | $2,688,000 | -64.7% | 2,790,964 | 0.0% | 2.89% | -63.3% |
| Q4 2019 | $7,619,000 | -30.7% | 2,790,964 | 0.0% | 7.86% | -67.8% |
| Q3 2019 | $10,996,000 | -3.2% | 2,790,964 | 0.0% | 24.40% | +33.2% |
| Q2 2019 | $11,359,000 | -42.0% | 2,790,964 | 0.0% | 18.32% | +43.4% |
| Q1 2019 | $19,593,000 | +28.8% | 2,790,964 | 0.0% | 12.78% | -15.5% |
| Q4 2018 | $15,211,000 | -49.3% | 2,790,964 | 0.0% | 15.11% | -14.1% |
| Q3 2018 | $29,975,000 | -17.6% | 2,790,964 | 0.0% | 17.60% | -14.7% |
| Q2 2018 | $36,366,000 | +18.2% | 2,790,964 | 0.0% | 20.62% | +257.7% |
| Q1 2018 | $30,756,000 | +9.5% | 2,790,964 | 0.0% | 5.76% | +14.0% |
| Q4 2017 | $28,077,000 | – | 2,790,964 | – | 5.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer VII & Co. Ltd. | 2,263,365 | $20,493,000 | 82.81% |
| Pharmstandard International S.A. | 1,037,267 | $10,435,000 | 10.73% |
| Partner Investment Management, L.P. | 575,407 | $4,724,000 | 5.44% |
| FRAZIER MANAGEMENT LLC | 3,330,373 | $33,504,000 | 5.43% |
| TRV GP II, LLC | 2,790,964 | $28,077,000 | 5.06% |
| SPHERA FUNDS MANAGEMENT LTD. | 325,000 | $3,270,000 | 0.38% |
| PFM Health Sciences, LP | 1,464,204 | $13,255,000 | 0.31% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 605,100 | $6,087,000 | 0.24% |
| Perceptive Advisors | 250,000 | $2,515,000 | 0.08% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 18,288 | $259,000 | 0.07% |